Cancer vaccine strategies using self-replicating RNA viral platforms

The development and success of RNA-based vaccines targeting SARS-CoV-2 has awakened new interest in utilizing RNA vaccines against cancer, particularly in the emerging use of self-replicating RNA (srRNA) viral vaccine platforms. These vaccines are based on different single-stranded RNA viruses, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dailey, Gabrielle P., Crosby, Erika J., Hartman, Zachary C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275542/
https://www.ncbi.nlm.nih.gov/pubmed/35821284
http://dx.doi.org/10.1038/s41417-022-00499-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275542/
https://www.ncbi.nlm.nih.gov/pubmed/35821284
http://dx.doi.org/10.1038/s41417-022-00499-6

Ejemplares similares